Cogent Biosciences, Inc. (COGT) Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors Transcript

Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors November 8:00 ...
Journal of Epidemiology and Community Health (JECH)

Impact of parental adverse childhood experiences on children’s healthcare utilisation: a systematic review

Background Adverse childhood experiences (ACEs) are linked to poor health and social outcomes, with growing interest in their ...
Idaho State Journal

Stop fearing and get some hormone help

This last week the FDA removed the black box warning label on hormone replacement therapy for menopause. When I heard this, I ...
The Lancet

Exploring CAR NK-cell therapy for refractory lupus

The treatment landscape for systemic lupus erythematosus (SLE) has shifted greatly in recent years, driven by the emergence ...
The Lancet

Scaling an intervention for the engagement of people with HIV who inject drugs into care in Viet Nam: an implementation-effectiveness, cluster-randomised trial

A tailored approach with rapid needs assessment before and during implementation to address local testing site barriers in ...
BMJ Open

Comparison of ciprofol versus propofol on gastrointestinal motility in patients undergoing laparoscopic radical resection for colorectal cancer: study protocol for a randomised ...

Background Postoperative ileus (POI) is a common complication after abdominal surgery that significantly delays recovery. Evidence suggests that the general anaesthetic propofol inhibits ...

Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting

Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...